Literature DB >> 10209502

The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium.

F Mota1, N Rayment, S Chong, A Singer, B Chain.   

Abstract

The activation of HPV-specific T cells within the cervical microenvironment is likely to play an important part in the natural history of cervical intraepithelial neoplasia (CIN). The extent and the type of T cell activation will depend critically on the expression of MHC, costimulatory cell surface molecules and cytokines by keratinocytes and Langerhans cells within the cervical lesion. Expression of MHC class II (HLA-A-DR and -DQ), costimulatory/adhesion molecules (CD11a/18, CD50, CD54, CD58 and CD86) and cytokines (tumour necrosis factor-alpha (TNF-alpha) and IL-10) was therefore investigated by immunohistochemistry in normal squamous epithelium (n = 12), low-grade (n = 23) and high-grade (n = 18) squamous intraepithelial lesions of the cervix. CIN progression was associated with de novo expression of HLA-DR and CD54, and increased expression of CD58 by keratinocytes. However, significantly, there was no expression of any adhesion/costimulation molecule by epithelial Langerhans cells in any cervical biopsy studied. Furthermore, TNF-alpha, a potent activator of Langerhans cells, was expressed constitutively by basal keratinocytes in normal cervix (12+/12). but expression of this cytokine was absent in a number of CIN samples (20+/23 for low-grade, 12+/18 for high-grade CIN). Conversely, the suppressive cytokine IL-10 was absent in normal epithelium (0+/12), but was up-regulated in a number of CIN lesions (12+/23 for low-grade; 8+/18 for high-grade CIN). The restricted expression of costimulation/adhesion molecules and the nature of the cytokine microenvironment within the epithelium may act to limit effective immune responses in some CIN lesions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10209502      PMCID: PMC1905217          DOI: 10.1046/j.1365-2249.1999.00826.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.

Authors:  A H Enk; V L Angeloni; M C Udey; S I Katz
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

Review 2.  Maturation and migration of cutaneous dendritic cells.

Authors:  R Steinman; L Hoffman; M Pope
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

Review 3.  Natural history of HLA expression during tumour development.

Authors:  F Garrido; T Cabrera; A Concha; S Glew; F Ruiz-Cabello; P L Stern
Journal:  Immunol Today       Date:  1993-10

4.  Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization.

Authors:  M Cumberbatch; I Kimber
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

5.  Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.

Authors:  B J Nickoloff; R S Mitra; J Green; X G Zheng; Y Shimizu; C Thompson; L A Turka
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

6.  Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization.

Authors:  A Lenz; M Heine; G Schuler; N Romani
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  Analysis of HLA-DR expression on keratinocytes in cervical neoplasia.

Authors:  N Coleman; M A Stanley
Journal:  Int J Cancer       Date:  1994-02-01       Impact factor: 7.396

8.  Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques.

Authors:  B J Nickoloff; D P Fivenson; S L Kunkel; R M Strieter; L A Turka
Journal:  Clin Immunol Immunopathol       Date:  1994-10

9.  Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions.

Authors:  K U Petry; D Scheffel; U Bode; T Gabrysiak; H Köchel; E Kupsch; M Glaubitz; S Niesert; H Kühnle; I Schedel
Journal:  Int J Cancer       Date:  1994-06-15       Impact factor: 7.396

10.  Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T cell activation.

Authors:  M B Teunissen; H A Rongen; J D Bos
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

View more
  32 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in Brazil.

Authors:  R T Simões; M A G Gonçalves; E A Donadi; A L Simões; J S R Bettini; G Duarte; S M Quintana; M W P Carvalho; E G Soares
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

3.  Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production.

Authors:  Jennifer C Guess; Dennis J McCance
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.

Authors:  Jian Ming Hu; Qi Sun; Ling Li; Chun Xia Liu; Yun Zhao Chen; Hong Zou; Li Juan Pang; Jin Zhao; Lan Yang; Yu Wen Cao; Xiao Bin Cui; Yan Qi; Wei Hua Liang; Wen Jie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

5.  Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.

Authors:  Margaret M Madeleine; Lisa G Johnson; Anajane G Smith; John A Hansen; Brenda B Nisperos; Sue Li; Lue-Ping Zhao; Janet R Daling; Stephen M Schwartz; Denise A Galloway
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

6.  Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.

Authors:  Lauren E Wilson; Michael Pawlita; Phillip E Castle; Tim Waterboer; Vikrant Sahasrabuddhe; Patti E Gravitt; Mark Schiffman; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2013-05-29       Impact factor: 7.396

Review 7.  The biological properties of E6 and E7 oncoproteins from human papillomaviruses.

Authors:  Raffaella Ghittoni; Rosita Accardi; Uzma Hasan; Tarik Gheit; Bakary Sylla; Massimo Tommasino
Journal:  Virus Genes       Date:  2009-10-17       Impact factor: 2.332

8.  Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.

Authors:  Joanna Laurson; Sadaf Khan; Rachel Chung; Karen Cross; Kenneth Raj
Journal:  Carcinogenesis       Date:  2010-02-01       Impact factor: 4.944

Review 9.  Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful.

Authors:  Sjoerd H van der Burg; Joel M Palefsky
Journal:  J Transl Med       Date:  2009-12-18       Impact factor: 5.531

10.  The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity.

Authors:  Maria Alice G Gonçalves; Edson G Soares; Eduardo A Donadi
Journal:  Infect Agent Cancer       Date:  2009-08-18       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.